SUMMARY C3 allotypes were defined in 86 Caucasoid patients with rheumatoid arthritis living in the north west of England and in 80 local, healthy controls. C3 allotype and phenotype frequencies were similar in RA (whether DR4 positive or negative) and control groups.
found to be between four and five times more frequent in DR4 positive RA as compared with DR4 positive haplotypes from non-RA families.6 However, it is unlikely that genetic predisposition to RA can be completely accounted for by genes linked to HLA and Gm, thus the above findings suggest that the complement genes themselves or genes linked to the complement genes may also influence susceptibility to RA.
Two previous studies have suggested an association between genetic variants of C3 (coded for by genes on chromosome 19) and RA. 7 8 In this study we have re-examined this association by comparing C3 allotype and phenotype frequencies in rheumatoid and control populations. As the previously described associations between RA and both Glm(x) and BfS were shown to be dependent on DR status we have also looked for evidence of an interaction between C3 and DR4. (Table 2) , and there were no significant differences between rheumatoid factor positive and negative patients (Table 3) .
Discussion
We have extended our study of immunogenetic markers in patients from the north west of England with RA by searching for an association with genetic variants of complement component C3. C3 allotype and phenotype frequencies were similar in RA and control groups, hence it was not possible to show any independent effect of C3 genes on susceptibility to RA. The C3 allotype and phenotype frequencies were also similar in DR4 positive and DR4 negative RA.
The gene frequencies for our control group are in keeping with previous reports of C3 polymorphism in European populations.'1 12 However, our results conflict with the two previous reports of C3 polymorphism in RA,7 8in which increases in the C3*F gene were found.
In the first study Farhud 
